7 results
424B5
BYSI
BeyondSpring Inc
7 Feb 20
Prospectus supplement for primary offering
4:16pm
with the goal of increasing compliance and persistency with prescribed chemotherapy regimens, the potential for maintenance of relative dose intensity
6-K
EX-99.2
n2t03fl
23 Oct 18
Current report (foreign)
9:17am
6-K
EX-99.1
4ak8f9gdwwyb32ngp
23 Oct 18
Current report (foreign)
9:17am
- Prev
- 1
- Next